Regulatory CD4⁺CD25⁺ T-cells are Controlled by Multiple Pathways at Multiple Levels

REFERENCES

• S. Read, V. Malmstrom, and F. Powrie, Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation, J. Exp. Med., 192: 295–302, 2000.
   PubMed Web of Science ®Google Scholar
• G. Zheng, B. Wang, and A. Chen, The 4-1BB costimulation augments the proliferation of CD4 + CD25 + regulatory T cells, J. Immunol, 173: 2428–2434, 2004.
   PubMed Web of Science ®Google Scholar
• J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance, Nat. Immunol., 3: 135–142, 2002.
   PubMed Web of Science ®Google Scholar
• B. Valzasina, C. Guiducci, H. Dislich, N. Killeen, A.D. Weinberg, and M.P. Colombo, Triggering of OX40 (CD134) on CD4(+)CD25 + T cells blocks their inhibitory activity: A novel regulatory role for OX40 and its comparison with GITR, Blood, 105: 2845–2851, 2005.
   PubMed Web of Science ®Google Scholar
• Q. Tang, K.J. Henriksen, E.K. Boden, A.J. Tooley, J. Ye, S.K. Subudhi, X.X. Zheng, T.B. Strom, and J.A. Bluestone, Cutting edge: CD28 controls peripheral homeostasis of CD4 + CD25 + regulatory T cells, J. Immunol., 171: 3348–3352, 2003.
   PubMed Web of Science ®Google Scholar
• E. Kreijveld, H.J. Koenen, L.B. Hilbrands, H.J. van Hooff, and I. Joosten, The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4 + CD25 − T cells, Blood, 109(1): 244–252, 2007.
   Google Scholar
• B. Birebent, R. Lorho, H. Lechartier, S. de Guibert, M. Alizadeh, N. Vu, A. Beauplet, N. Robillard, and G. Semana, Suppressive properties of human CD4 + CD25 + regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol., 34: 3485–3496, 2004.
   PubMed Web of Science ®Google Scholar
• B.K. Choi, J.S. Bae, E.M. Choi, W.J. Kang, S. Sakaguchi, D.S. Vinay, and B.S. Kwon, 4-1BB-dependent inhibition of immunosuppression by activated CD4 + CD25 + T cells, J. Leukoc. Biol., 75: 785–791, 2004.
   PubMedGoogle Scholar
• R.J. Greenwald, G.J. Freeman, and A.H. Sharpe, The B7 family revisited, Annu. Rev. Immunol., 23: 515–548, 2005.
   PubMed Web of Science ®Google Scholar
• I. Takeda, S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii, Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells, J. Immunol., 172: 3580–3589, 2004.
   PubMed Web of Science ®Google Scholar
• N. Seddiki, B. Santner-Nanan, S.G. Tangye, S.I. Alexander, M. Solomon, S. Lee, R. Nanan, and B.F. de Saint Groth, Persistence of naive CD45RA + regulatory T cells in adult life, Blood, 107: 2830–2838, 2006.
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, Naturally arising CD4 + regulatory t cells for immunologic self-tolerance and negative control of immune responses, Annu. Rev. Immunol., 22: 531–562, 2004.
   PubMed Web of Science ®Google Scholar
• E.M. Shevach, CD4 + CD25 + suppressor T cells: More questions than answers, Nat. Rev. Immunol., 2: 389–400, 2002.
   PubMed Web of Science ®Google Scholar
• Y. Miura, C.J. Thoburn, E.C. Bright, S. Arai, and A.D. Hess, Regulation of OX40 gene expression in graft-versus-host disease, Transplant. Proc., 37: 57–61, 2005.
   Google Scholar
• R.M. Steinman and M.C. Nussenzweig, Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance, Proc. Natl. Acad. Sci. U. S. A., 99: 351–358, 2002.
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, Naturally arising FoxP3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self, Nat. Immunol., 6: 345–352, 2005.
   PubMed Web of Science ®Google Scholar
• J.C. Ochando, C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, R. Jessberger, G. Trinchieri, S.A. Lira, G.J. Randolph, and J.S. Bromberg, Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts, Nat. Immunol., 7: 652–662, 2006.
   PubMed Web of Science ®Google Scholar
• Z. Fehervari and S. Sakaguchi, Control of FoxP3 + CD25 + CD4 + regulatory cell activation and function by dendritic cells, Int. Immunol., 16: 1769–1780, 2004.
   PubMed Web of Science ®Google Scholar
• W.P. Min, D. Zhou, T.E. Ichim, G.H. Strejan, X. Xia, J. Yang, X. Huang, B. Garcia, D. White, P. Dutartre, A.M. Jevnikar, and R. Zhong, Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance, J. Immunol., 170: 1304–1312, 2003.
   PubMed Web of Science ®Google Scholar
• N. Watanabe, Y.H. Wang, H.K. Lee, T. Ito, Y.H. Wang, W. Cao, and Y.J. Liu, Hassall's corpuscles instruct dendritic cells to induce CD4 + CD25 + regulatory T cells in human thymus, Nature., 436: 1181–1185, 2005.
   PubMed Web of Science ®Google Scholar
• Y.J. Liu, A unified theory of central tolerance in the thymus, Trends. Immunol., 27: 215–221, 2006.
   Google Scholar
• K.V. Tarbell, S. Yamazaki, K. Olson, P. Toy, and R.M. Steinman, CD25 + CD4 + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes, J. Exp. Med., 199: 1467–1477, 2004.
   PubMed Web of Science ®Google Scholar
• F. Ghiringhelli, P.E. Puig, S. Roux, A. Parcellier, E. Schmitt, E. Solary, G. Kroemer, F. Martin, B. Chauffert, and L. Zitvogel, Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4 + CD25 + regulatory T cell proliferation, J. Exp. Med., 202: 919–929, 2005.
   PubMed Web of Science ®Google Scholar
• S. Yamazaki, M. Patel, A. Harper, A. Bonito, H. Fukuyama, M. Pack, K.V. Tarbell, M. Talmor, J.V. Ravetch, K. Inaba, and R.M. Steinman, Effective expansion of alloantigen-specific FoxP3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction, Proc. Natl. Acad. Sci. U. S. A., 103: 2758–2763, 2006.
   PubMed Web of Science ®Google Scholar
• S. Fisson, F. Djelti, A. Trenado, F. Billiard, R. Liblau, D. Klatzmann, J.L. Cohen, and B.L. Salomon, Therapeutic potential of self-antigen-specific CD4 + CD25 + regulatory T cells selected in vitro from a polyclonal repertoire, Eur. J. Immunol., 36: 817–827, 2006.
   Google Scholar
• N.K. Crellin, R.V. Garcia, O. Hadisfar, S.E. Allan, T.S. Steiner, and M.K. Levings, Human CD4 + T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4 + CD25 + T regulatory cells, J. Immunol., 175: 8051–8059, 2005.
   PubMed Web of Science ®Google Scholar
• Y. Cong, A. Konrad, N. Iqbal, R.D. Hatton, C.T. Weaver, and C.O. Elson, Generation of antigen-specific, FoxP3-expressing CD4 + regulatory T cells by inhibition of APC proteosome function, J. Immunol., 174: 2787–2795, 2005.
   Google Scholar
• C. Pasare and R. Medzhitov, Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells, Science, 299: 1033–1036, 2003.
   PubMed Web of Science ®Google Scholar
• L.C. Ndhlovu, I. Takeda, K. Sugamura, and N. Ishii, Expanding role of T-cell costimulators in regulatory T-cell function: Recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells, Crit. Rev. Immunol., 24: 251–266, 2004.
   PubMedGoogle Scholar
• B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone, B7/CD28 costimulation is essential for the homeostasis of the CD4 + CD25 + immunoregulatory T cells that control autoimmune diabetes, Immunity, 12: 431–440, 2000.
   PubMed Web of Science ®Google Scholar
• X. Tai, M. Cowan, L. Feigenbaum, and A. Singer, CD28 costimulation of developing thymocytes induces FoxP3 expression and regulatory T cell differentiation independently of interleukin 2, Nat. Immunol., 6: 152–162, 2005.
   PubMed Web of Science ®Google Scholar
• K. Kronfeld, E. Hochleitner, S. Mendler, J. Goldschmidt, R. Lichtenfels, F. Lottspeich, H. Abken, and B. Seliger, B7/CD28 costimulation of T cells induces a distinct proteome pattern, Mol. Cell. Proteomics., 4: 1876–1887, 2005.
   Google Scholar
• S.G. Zheng, J.H. Wang, W. Stohl, K.S. Kim, J.D. Gray, and D.A. Horwitz, TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4 + CD25 + regulatory cells, J. Immunol., 176: 3321–3329, 2006.
   PubMed Web of Science ®Google Scholar
• H. Kataoka, S. Takahashi, K. Takase, S. Yamasaki, T. Yokosuka, T. Koike, and T. Saito, CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4, Int. Immunol., 17: 421–427, 2005.
   PubMed Web of Science ®Google Scholar
• A. Kumanogoh, X. Wang, I. Lee, C. Watanabe, M. Kamanaka, W. Shi, K. Yoshida, T. Sato, S. Habu, M. Itoh, N. Sakaguchi, S. Sakaguchi, and H. Kikutani, Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development, J. Immunol., 166: 353–360, 2001.
   PubMed Web of Science ®Google Scholar
• C. Guiducci, B. Valzasina, H. Dislich, and M.P. Colombo, CD40/CD40L interaction regulates CD4 + CD25 + T reg homeostasis through dendritic cell-produced IL-2, Eur. J. Immunol., 35: 557–567, 2005.
   PubMed Web of Science ®Google Scholar
• L.Z. Jarvinen, B.R. Blazar, O.A. Adeyi, T.B. Strom, and R.J. Noelle, CD154 on the surface of CD4 + CD25 + regulatory T cells contributes to skin transplant tolerance, Transplantation, 76: 1375–1379, 2003.
   Google Scholar
• S.A. Nanji, W.W. Hancock, B. Luo, C.D. Schur, R.L. Pawlick, L.F. Zhu, C.C. Anderson, and A.M. Shapiro, Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse, Diabetes, 55: 27–33, 2006.
   PubMed Web of Science ®Google Scholar
• P. Serra, A. Amrani, J. Yamanouchi, B. Han, S. Thiessen, T. Utsugi, J. Verdaguer, and P. Santamaria, CD40 ligation releases immature dendritic cells from the control of regulatory CD4 + CD25 + T cells, Immunity, 19: 877–889, 2003.
   PubMed Web of Science ®Google Scholar
• G.L. Stephens, R.S. McHugh, M.J. Whitters, D.A. Young, D. Luxenberg, B.M. Carreno, M. Collins, and E.M. Shevach, Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4 + CD25 + T cells, J. Immunol., 173: 5008–5020, 2004.
   PubMed Web of Science ®Google Scholar
• J. Lee, E.N. Lee, E.Y. Kim, H.J. Park, C.Y. Chang, D.Y. Jung, S.Y. Choi, S.K. Lee, K.W. Lee, G.Y. Kwon, J.W. Joh, and S.J. Kim, Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease, Immunol. Lett., 101: 210–216, 2005.
   PubMed Web of Science ®Google Scholar
• P.A. Taylor, A. Panoskaltsis-Mortari, J.M. Swedin, P.J. Lucas, R.E. Gress, B.L. Levine, C.H. June, J.S. Serody, and B.R. Blazar, L-Selectin(hi) but not the L-selectin(lo) CD4 + 25 + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection, Blood., 104: 3804–3812, 2004.
   PubMed Web of Science ®Google Scholar
• J. Ermann, P. Hoffmann, M. Edinger, S. Dutt, F.G. Blankenberg, J.P. Higgins, R.S. Negrin, C.G. Fathman, and S. Strober, Only the CD62L + subpopulation of CD4 + CD25 + regulatory T cells protects from lethal acute GVHD, Blood., 105: 2220–2226, 2005.
   PubMed Web of Science ®Google Scholar
• C.T. Huang, C.J. Workman, D. Flies, X. Pan, A.L. Marson, G. Zhou, E.L. Hipkiss, S. Ravi, J. Kowalski, H.I. Levitsky, J.D. Powell, D.M. Pardoll, C.G. Drake, and D.A. Vignali, Role of LAG-3 in regulatory T cells, Immunity, 21: 503–513, 2004.
   PubMed Web of Science ®Google Scholar
• D. Bruder, M. Probst-Kepper, A.M. Westendorf, R. Geffers, S. Beissert, K. Loser, H. von Boehmer, J. Buer, and W. Hansen, Neuropilin-1: A surface marker of regulatory T cells, Eur. J. Immunol., 34: 623–630, 2004.
   PubMed Web of Science ®Google Scholar
• J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nat. Immunol., 6: 1142–1151, 2005.
   PubMed Web of Science ®Google Scholar
• R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi, Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, J. Exp. Med., 201: 723–735, 2005.
   PubMed Web of Science ®Google Scholar
• M. de la Rosa, S. Rutz, H. Dorninger, and A. Scheffold, Interleukin-2 is essential for CD4 + CD25 + regulatory T cell function, Eur. J. Immunol., 34: 2480–2488, 2004.
   PubMed Web of Science ®Google Scholar
• A.M. Thornton, E.E. Donovan, C.A. Piccirillo, and E.M. Shevach, Cutting edge: IL-2 is critically required for the in vitro activation of CD4 + CD25 + T cell suppressor function, J. Immunol., 172: 6519–6523, 2004.
   PubMed Web of Science ®Google Scholar
• E. Zorn, E.A. Nelson, M. Mohseni, F. Porcheray, H. Kim, D. Litsa, R. Bellucci, E. Raderschall, C. Canning, R.J. Soiffer, D.A. Frank, and J. Ritz, IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT dependent mechanism and induces the expansion of these cells in vivo, Blood., 2006.
   Google Scholar
• A. Scheffold, J. Huhn, and T. Hofer, Regulation of CD4 + CD25 + regulatory T cell activity: It takes (IL-)two to tango, Eur. J. Immunol., 35: 1336–1341, 2005.
   PubMed Web of Science ®Google Scholar
• B. H. Nelson, IL-2, regulatory T cells, and tolerance, J. Immunol., 172: 3983–3988, 2004.
   PubMed Web of Science ®Google Scholar
• J. Harnaha, J. Machen, M. Wright, R. Lakomy, A. Styche, M. Trucco, S. Makaroun, and N. Giannoukakis, Interleukin-7 is a survival factor for CD4 + CD25 + T-cells and is expressed by diabetes-suppressive dendritic cells, Diabetes, 55: 158–170, 2006.
   PubMed Web of Science ®Google Scholar
• K.C. Herold, J.B. Burton, F. Francois, E. Poumian-Ruiz, M. Glandt, and J.A. Bluestone, Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala) J. Clin. Invest., 111: 409–418, 2003.
   PubMed Web of Science ®Google Scholar
• W. Liu, A.L. Putnam, Z. Xu-Yu, G.L. Szot, M.R. Lee, S. Zhu, P.A. Gottlieb, P. Kapranov, T.R. Gingeras, B.F. de St Groth, C. Clayberger, D.M. Soper, S.F. Ziegler, and J.A. Bluestone, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells, J. Exp. Med., 203: 1701–1711, 2006.
   PubMed Web of Science ®Google Scholar
• N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S.I. Alexander, R. Nanan, A. Kelleher, and B. Fazekas de St Groth, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, J. Exp. Med., 203: 1693–1700, 2006.
   PubMed Web of Science ®Google Scholar
• A. Sundstedt, E.J. O'Neill, K.S. Nicolson, and D.C. Wraith, Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo, J. Immunol., 170: 1240–1248, 2003.
   PubMed Web of Science ®Google Scholar
• P.L. Vieira, J.R. Christensen, S. Minaee, E.J. O'Neill, F.J. Barrat, A. Boonstra, T. Barthlott, B. Stockinger, D.C. Wraith, and A. O'Garra, IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 + CD25 + regulatory T cells, J. Immunol., 172: 5986–5993, 2004.
   PubMed Web of Science ®Google Scholar
• V. Smart, P.S. Foster, M.E. Rothenberg, T.J. Higgins, and S.P. Hogan, A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4 + CD45RBlow T cell-dependent mechanism, J. Immunol., 171: 2116–2126, 2003.
   PubMed Web of Science ®Google Scholar
• A. Foussat, F. Cottrez, V. Brun, N. Fournier, J.P. Breittmayer, and H. Groux, A comparative study between T regulatory type 1 and CD4 + CD25 + T cells in the control of inflammation, J. Immunol., 171: 5018–5026, 2003.
   PubMed Web of Science ®Google Scholar
• M.J. McGeachy, L.A. Stephens, and S.M. Anderton, Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4 + CD25 + regulatory cells within the central nervous system, J. Immunol., 175: 3025–3032, 2005.
   PubMed Web of Science ®Google Scholar
• D. Javelaud and A. Mauviel, Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles, Int. J. Biochem. Cell. Biol., 36 1161–1165, 2004.
   PubMed Web of Science ®Google Scholar
• K. Nakamura, A. Kitani, and W. Strober, Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J. Exp. Med., 194: 629–644, 2001.
   PubMed Web of Science ®Google Scholar
• S. Huber, C. Schramm, H.A. Lehr, A. Mann, S. Schmitt, C. Becker, M. Protschka, P.R. Galle, M.F. Neurath, and M. Blessing, Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4 + CD25 + T cells, J. Immunol., 173: 6526–6531, 2004.
   PubMed Web of Science ®Google Scholar
• W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and S.M. Wahl, Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3, J. Exp. Med., 198: 1875–1886, 2003.
   PubMed Web of Science ®Google Scholar
• P.E. Rao, A.L. Petrone, and P.D. Ponath, Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}, J. Immunol., 174: 1446–1455, 2005.
   PubMed Web of Science ®Google Scholar
• M.C. Fantini, C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath, Cutting edge: TGF-beta induces a regulatory phenotype in CD4 + CD25- T cells through Foxp3 induction and down-regulation of Smad7, J. Immunol., 172: 5149–5153, 2004.
   PubMed Web of Science ®Google Scholar
• Y. Peng, Y. Laouar, M.O. Li, E.A. Green, and R.A. Flavell, TGF-beta regulates in vivo expansion of Foxp3-expressing CD4 + CD25 + regulatory T cells responsible for protection against diabetes, Proc. Natl. Acad. Sci. U.S.A., 101: 4572–4577, 2004.
   PubMed Web of Science ®Google Scholar
• S. Diehl, C.W. Chow, L. Weiss, A. Palmetshofer, T. Twardzik, L. Rounds, E. Serfling, R.J. Davis, J. Anguita, and M. Rincon, Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation, J. Exp. Med., 196: 39–49, 2002.
   PubMed Web of Science ®Google Scholar
• A. Doganci, K. Sauer, R. Karwot, and S. Finotto, Pathological role of IL-6 in the experimental allergic bronchial asthma in mice, Clin. Rev. Allergy. Immunol., 28: 257–270, 2005.
   PubMed Web of Science ®Google Scholar
• H.H. Oberg, D. Wesch, S. Grussel, S. Rose-John, and D. Kabelitz, Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4 + CD25 − and CD25high regulatory T cells, Int. Immunol., 18: 555–563, 2006.
   PubMed Web of Science ®Google Scholar
• E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441: 235–238, 2006.
   PubMed Web of Science ®Google Scholar
• H.P. Eugster, K. Frei, F. Winkler, U. Koedel, W. Pfister, H. Lassmann, and A. Fontana, Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway, Eur. J. Immunol., 31: 2302–2312, 2001.
   PubMed Web of Science ®Google Scholar
• J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky, Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells, Nat. Immunol., 4: 330–336, 2003.
   PubMed Web of Science ®Google Scholar
• S. Hori, T. Nomura, and S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3, Science., 299: 1057–1061, 2003.
   PubMed Web of Science ®Google Scholar
• W.R. Godfrey, Y.G. Ge, D.J. Spoden, B.L. Levine, C.H. June, B.R. Blazar, and S.B. Porter, In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures, Blood, 104: 453–461, 2004.
   PubMed Web of Science ®Google Scholar
• E. Bettelli, M. Dastrange, and M. Oukka, Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells, Proc. Natl. Acad. Sci. U.S.A, 102: 5138–5143, 2005.
   PubMed Web of Science ®Google Scholar
• F. Ocklenburg, D. Moharregh-Khiabani, R. Geffers, V. Janke, S. Pfoertner, H. Garritsen, L. Groebe, J. Klempnauer, K.E. Dittmar, S. Weiss, J. Buer, and M. Probst-Kepper, UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells, Lab. Invest., 2006.
   Google Scholar
• S. Koonpaew, S. Shen, L. Flowers, and W. Zhang, LAT-mediated signaling in CD4 + CD25 + regulatory T cell development, J. Exp. Med., 203: 119–129, 2006.
   PubMed Web of Science ®Google Scholar
• H. Liu, M. Komai-Koma, D. Xu, and F.Y. Liew, Toll-like receptor 2 signaling modulates the functions of CD4 + CD25 + regulatory T cells, Proc. Natl. Acad. Sci. U.S.A., 103: 7048–7053, 2006.
   PubMed Web of Science ®Google Scholar